ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Proposes To Require Electronic Submission

May 3, 2002

Battelle Wins Big Toxiology Contract

March 22, 1974

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

AACR Presents Awards at Annual Meeting

April 5, 2013

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989